Jaguar Health (JAGX) Other financing activities (2015 - 2023)

Jaguar Health (JAGX) has 9 years of Other financing activities data on file, last reported at -$2000.0 in Q4 2023.

• On a quarterly basis, Other financing activities changed N/A year-over-year to -$2000.0 in Q4 2023; TTM through Jun 2024 was -$2000.0, a 99.58% increase from a year earlier, with the FY2023 full-year figure at $1.2 million, changed N/A from the prior year.
• Other financing activities for Q4 2023 stood at -$2000.0, down from $3000.0 in the prior quarter.
• Over the last five years, Other financing activities for JAGX reached as high as $5.5 million in Q4 2020 and fell as low as -$1.5 million in Q4 2021.
• Historically, Other financing activities has averaged $654916.7 across 5 years, with a median of $219867.0 in 2019.
• Across the five-year window, Other financing activities surged 2249.68% in 2020 and sank 127.84% in 2021, its largest moves.
• Year by year, Other financing activities stood at $233734.0 in 2019, then jumped by 2249.68% to $5.5 million in 2020, then sank by 127.84% to -$1.5 million in 2021, then surged by 88.36% to -$178000.0 in 2022, then soared by 98.88% to -$2000.0 in 2023.
• Per Business Quant data, the three most recent Other financing activities figures were -$2000.0 in Q4 2023, $3000.0 in Q2 2023, and $1.2 million in Q1 2023.